Facial Angiofibroma Associated with TSC and How Can it Be Managed? скачать в хорошем качестве

Facial Angiofibroma Associated with TSC and How Can it Be Managed?

Presenter: Joyce M. C. Teng, MD, PhD, Professor of Dermatology & Pediatrics, Stanford University Moderator: Eric Beresford, PharmD, BCMAS, Vice President and Head of Medical Affairs, Nobelpharma America Facial angiofibroma is one of the most visible signs of tuberous sclerosis complex (TSC) and occurs in approximately 75%-80% of TSC patients. If left untreated, facial angiofibroma can cause disfigurement. Patients have reported that facial angiofibroma can have negative effects on appearance and self-image, and the tumors may be a psychological and social burden for people living with this condition. In this webinar session, Dr. Joyce Teng, Professor of Dermatology and Pediatrics, Stanford University and Eric Beresford, Vice President and Head of Medical Affairs, Nobelpharma America, guide attendees in exploring: 1. What Is Facial Angiofibroma Associated with TSC? 2. The Social and Psychological Impact of Facial Angiofibroma 3. Taking Care of Your Skin 4. What to Know About Treatments Download Dr. Teng's Presentation: https://bit.ly/3RMwkFl This webinar was sponsored by Nobelpharma America, LLC. To learn more about our Research Education Webinar Series, visit tscalliance.org/webinars.